Clearbridge Health Ltd 2025 AR2
The report highlights Clearbridge Health Limited's sustainability performance and strategic developments for the fiscal year 2025. The company launched its adult immune cell banking business in Hong Kong and Southeast Asia, marking a transition toward precision medicine. Financially, Clearbridge recorded stable revenue of S$9.93 million, with growth in renal care services in the Philippines offsetting headwinds in Singapore's dental clinics. On the environmental front, the company tracked its Scope 2 emissions, which increased by 26.49% due to expanded activities in the Philippines, and managed 13,718 kg of hazardous and non-hazardous waste. Clearbridge also maintained its commitment to local communities through medical missions and food assistance.
Company: Clearbridge Health Ltd
Sector: Healthcare & social services
Country: Singapore
Year: 2025
Type: AR2
Pages: 200
Back to company
Clearbridge Health Ltd
Annual Report
The report highlights Clearbridge Health Limited's sustainability performance and strategic developments for the fiscal year 2025. The company launched its adult immune cell banking business in Hong Kong and Southeast Asia, marking a transition toward precision medicine. Financially, Clearbridge recorded stable revenue of S$9.93 million, with growth in renal care services in the Philippines offsetting headwinds in Singapore's dental clinics. On the environmental front, the company tracked its Scope 2 emissions, which increased by 26.49% due to expanded activities in the Philippines, and managed 13,718 kg of hazardous and non-hazardous waste. Clearbridge also maintained its commitment to local communities through medical missions and food assistance.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Jan 1, 2025 - Dec 31, 2025
Fiscal Year
2025
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees